Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.
about
Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriersAshkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic diseasePotential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian CancerViewing systematic reviews and meta-analysis in social research through different lenses.Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriersCalibration of quality-adjusted life years for oncology clinical trials.Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer.Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomyEfficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations.Cancer genetics services: a systematic review of the economic evidence and issues.Online tool to guide decisions for BRCA1/2 mutation carriers."Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospitalThe Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA CarriersBRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.Methods in comparative effectiveness research.Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer.Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.Economic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease.Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto RicoNew insights into breast cancer genetics and impact on patient managementMeta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriersCould triaging family history of cancer during palliative care enable earlier genetic counseling intervention?Economic methods for valuing the outcomes of genetic testing: beyond cost-effectiveness analysis.The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent.Genetic risk and gynecologic cancers.Familial breast cancer: is it time to move from a reactive to a proactive role?Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing.Risk-reducing salpingectomy: Let us be opportunistic.Family stories and the use of heuristics: women from suspected hereditary breast and ovarian cancer (HBOC) families.Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer RiskDevelopment of an integrated support system for hereditary cancer and its impact on gynecologic services.A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families.Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.
P2860
Q24654487-50A37585-1F5A-4C62-8B17-829483C3D470Q24675652-B15C686D-1FFE-4440-AF47-79097911B262Q33416772-D972A30C-4AB5-4D65-B619-D11C50B37634Q34152848-1C9883B5-4DC4-4172-958E-3E27E2FEB096Q34206816-87B62544-2467-43E1-B81A-B1B565403C28Q34309892-0DCB6599-9651-4697-A66B-A7BE20017413Q34321847-2D226F44-8559-44A4-8759-7E925254A8C8Q34434006-69FDAE1B-D6E6-4D95-A694-EAF6DAB4BE2EQ34630227-62411DDE-E74B-4D51-8F8C-2F509C43046AQ34663394-28639DBF-1E9E-4BFE-83D9-887C051A78EEQ35039478-5E7E1C17-E1BA-4755-B532-6AFABB337BD7Q35073191-82DB02F4-C39C-4E3B-B567-78BD56F9BDD0Q35675838-228CC3EF-3739-4278-A28D-C366BBB9F156Q35776962-F4B4608D-1D39-44B3-9535-58ECB2B9DEB6Q35808372-609384E3-AB44-4137-A75A-391DDD1E7B96Q35901573-E17F86D4-08D1-49E8-8E58-0DD1700B3677Q36218446-28D8E5F8-ED36-42F6-B33B-A1495837A2DBQ36315223-30D084D3-6A6B-41F6-9EA4-EF0A2F04BC2BQ36417734-E897B137-E165-4351-8D85-6459A3359AF8Q36694081-1516B152-0E06-4DC7-80FE-50E36D7878D9Q36738628-E1200A19-C1BC-4F34-A4F1-CFC0B1DD3F77Q36848099-2B14AE8D-3734-480C-84A8-BD2F0A7F342BQ36849117-D5CA8B0A-838D-4841-B530-CBE34006C683Q36883664-79960C09-2BB6-4529-95C9-B02AA0E49826Q37090813-7BB939D9-C9A2-44D0-B0A0-54EC16519652Q37293563-410029F1-2D4F-4845-9F21-29641F38B68FQ37315305-ACBF83C5-D427-43FF-95DE-1873378BD08DQ37327609-BFE45D28-91CA-41DC-A0A9-CD9229B56655Q37468316-B3E1FCA3-9D41-4D9E-9A9A-735BA832B0B0Q37852628-7B20B97D-D593-4C44-BBD3-49598099A730Q38241489-83F2261E-2D45-45BC-9EAD-8E5AC3DF2982Q38599703-9B49A383-0920-4A87-BBFC-E8F0FFA18677Q38732720-218CD0A4-3FC0-4943-8F4D-DAF8295B3603Q38850381-477E3CA1-38FC-465D-969B-3608CFDA46CCQ39196159-2F731D64-7BF6-4548-8190-B57D4C06A2ACQ40552820-3536F7A1-8412-4E01-B9A4-3FCB3DF2ECB2Q42385500-51A095C8-EBEA-4BD0-A932-8A741CD43F05Q43749121-D7B63A71-4640-4A24-A405-DF3DE1EFC844Q46449074-FDDA395F-4F1D-4AD4-9068-1CC65808FFFEQ46971163-DB876F70-4F1A-4F32-9896-A45571306C7F
P2860
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Effect of prevention strategie ...... an updated decision analysis.
@en
Effect of prevention strategie ...... an updated decision analysis.
@nl
type
label
Effect of prevention strategie ...... an updated decision analysis.
@en
Effect of prevention strategie ...... an updated decision analysis.
@nl
prefLabel
Effect of prevention strategie ...... an updated decision analysis.
@en
Effect of prevention strategie ...... an updated decision analysis.
@nl
P2093
P356
P1476
Effect of prevention strategie ...... an updated decision analysis.
@en
P2093
Alfred I Neugut
Daniel F Heitjan
Dustin Thomason
Judith S Jacobson
Victor R Grann
P304
P356
10.1200/JCO.2002.10.101
P407
P577
2002-05-01T00:00:00Z